Navigation Links
JCI early table of contents for April 9, 2012
Date:4/9/2012

EDITOR'S PICK

Moving toward a better treatment for autoimmune diabetes

Insulin is required for the regulation of blood sugar levels. In type I diabetes, the cells that produce insulin are destroyed by the immune system. Chantal Mathieu and colleagues at the University of Leuven have attempted to circumvent this response by taking advantage of the fact that the immune system accepts foreign gut bacteria. The Mathieu group engineered gut bacteria so that they produce a form of insulin, and asked if these bacteria could retrain the immune system in mice with type I diabetes to accept insulin-producing cells. They found that these special bacteria increased the frequency of cured mice when compared to traditional methods alone, with seemingly no undesirable effects. Traditional methods suppress the immune system, which brings with it unfavorable consequences such as increased infections. In fact the Mathieu group confirmed that the immune system functioned in the mice following treatment. Their study provides a promising step towards the ability to reverse type I diabetes, as well as other autoimmune disorders, without incurring adverse side effects.


'/>"/>

Contact: Sarah Jackson
press_releases@the-jci.org
Journal of Clinical Investigation
Source:Eurekalert

Page: 1

Related medicine news :

1. Treat Rheumatoid Arthritis Early and Aggressively: Guidelines
2. Early Study Finds Some Promise for Lung Cancer Vaccine
3. An Early Start for Your Child with Autism
4. New Stool Test Might Aid in Early Detection of Colon Cancer
5. Arteries under pressure early on
6. Early clinical data show galeterone safe, effective against prostate cancer
7. Warm Weather Triggers Early Allergy Season
8. Genetic causes found in nearly 1 in 5 patients with dilated cardiomyopathy heart failure
9. Research gives hope to detecting cancer in early stages
10. Nearly all states have taken action on Affordable Care Acts Patients Bill of Rights
11. Statin Alternative Looks Promising in Early Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... ... through affiliations and de novo development, today announced Cumberland Skin Surgery and ... Skin Surgery and Dermatology, with offices in both Hermitage and Lebanon, Tennessee, provides ...
(Date:8/16/2017)... ... ... LabRoots , the leading provider of educational and interactive virtual events ... Andrew Ly as the winner of the LabRoots Summer Textbook scholarship, awarding him $1000 ... is in his third year at the University of California, Los Angeles majoring in ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... Fusion Flix ... premium original programming over four countries and millions of viewers in a partnership with ... rent or buy On-Demand and fully available on Blu Ray disc in 2018. Proceeds ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... new client win in the healthcare market, with Los Angeles-based AIDS Healthcare Foundation ... staff and members. , AHF cares for nearly 800,000 individuals worldwide and is ...
(Date:8/16/2017)... ... 2017 , ... Rollon Skin Care Ltd., one ... announced the launch of two new skincare products, Prache Antiaging Cream and Prache ... plastic surgery or in-patient cosmetic dermatological procedures. , “Prache Antiaging Cream and Prache ...
Breaking Medicine News(10 mins):
(Date:8/2/2017)... , Aug. 2, 2017 CaryRx, a next-generation ... day delivery service for patients in the Washington ... traditional retail pharmacy by providing delivery of medications through the ... for future delivery or delivered within one hour to any ... are excited to bring this invaluable service to ...
(Date:7/31/2017)... 7D Surgical, developer of ground breaking surgical navigation ... Surgical System to support its strategic sales plan in ... and Virginia.  7D Surgical has entered into an exclusive sales ... medical facilities within those markets. ... Spartan Medical Purchases ...
(Date:7/27/2017)... 2017  West Pharmaceutical Services, Inc. (NYSE: ... second-quarter 2017 and updated financial guidance for the full-year ... Highlights Reported net sales of $397.6 ... quarter. Net sales at constant currency (organic) grew by ... $0.51, compared to $0.60 in the prior-year quarter. Second-quarter ...
Breaking Medicine Technology: